Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21870121
Conclusion of this study
The improvement of cognitive deficits, the reduction of ammonia, and the modification of EEG in patients treated with ALC suggest that ALC could represent a new tool in the treatment of severe hepatic encephalopathy.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study